Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.
about
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cellsA Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast CancerMaximum a posteriori Bayesian estimation of epirubicin clearance by limited samplingAssessment of the validity of a population pharmacokinetic model for epirubicin.New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.Level of evidence for therapeutic drug monitoring of taxanes.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.
P2860
Q24813485-4A0EBC35-F326-439D-A106-690588F53AECQ33559358-FE57F20A-96A1-4CCC-87F3-CB0F2508002DQ33598372-FB41C4E9-F92B-4B12-A379-695DAC6CC434Q34779654-9AC43174-5CED-4C96-B4A6-19BD733605AEQ35826177-68B0BC9D-2639-4841-9E83-E3B8AC64C5D6Q35827620-67BD92C0-8EE0-42F8-BE5F-A4B913FB4F5CQ37355919-FA9158EF-239D-49F3-BA4C-C445AC5EF019Q37788732-6EF6BDFD-2891-4BC0-B227-1FF3B9BFB2E4Q38047337-B8229A33-1953-4E67-8A2E-ADB86A9F8B73Q43785986-1F4E8F66-2AEF-4AD5-B2D7-FE6FFAD496B0Q44067892-9836CEF8-883D-4038-90B9-CFB3B621B470
P2860
Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@ast
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@en
type
label
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@ast
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@en
prefLabel
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@ast
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@en
P1476
Pharmacokinetic optimisation o ...... itaxel in patients with cancer
@en
P2093
M Del Tacca
P304
P356
10.2165/00003088-199937030-00002
P577
1999-09-01T00:00:00Z
P6179
1019763578